Stock Price
18.84
Daily Change
-0.13 -0.69%
Monthly
-12.62%
Yearly
36.92%
Q4 Forecast
18.39



Peers Price Chg Day Year Date
Agrana Beteiligungs 11.45 0.10 0.88% -7.66% Oct/05
Austevoll Seafood 82.30 -0.20 -0.24% -13.64% Oct/05
British American Tobacco 3,978.00 18.00 0.45% 5.10% Oct/05
Beiersdorf 75.74 0.34 0.45% -16.60% Oct/05
Danone 57.76 -1.36 -2.30% -20.11% Oct/05
Givaudan 3,381.00 21.00 0.63% 4.67% Oct/05
Glanbia 18.84 -0.13 -0.69% 36.92% Oct/05
Henkel 71.66 -0.64 -0.89% 3.23% Oct/05
International Flavors Fragrances 83.67 1.25 1.52% 36.05% Oct/05
Imperial Brands 2,450.00 7.00 0.29% -18.44% Oct/05

Indexes Price Day Year Date
ISEQ 14316 57.27 0.40% 22.58% Oct/05
EU600 634 2.27 0.36% 11.11% Oct/05

Glanbia traded at 18.84 this Monday October 5th, decreasing 0.13 or 0.69 percent since the previous trading session. Looking back, over the last four weeks, Glanbia lost 12.62 percent. Over the last 12 months, its price rose by 36.92 percent. Looking ahead, we forecast Glanbia to be priced at 18.39 by the end of this quarter and at 16.75 in one year, according to Trading Economics global macro models projections and analysts expectations.

Glanbia plc is a global nutrition company. The Company operates through two segments: Glanbia Performance Nutrition and Glanbia Nutritionals. The Company's Glanbia Performance Nutrition segment includes performance nutrition products. Its products are sold through a range of channels, including specialty retail, the Internet and gyms in a range of formats, including powders, bars and ready-to-drink beverages. The Company's Glanbia Nutritionals segment provides nutritional solutions. It manufactures and sells cheese, dairy and non-dairy nutritional ingredients and vitamin and mineral premixes targeting the market focus on health and nutrition.